Phacilitate Leaders World 

Features, Workshops & Networking Agenda

Loading

The power of perseverance - how Dendreon bounced back

23 Jan 2019
Phacilitate: Talks
  • Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.
  • Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. 
  • While the journey, which began in 1992, has been filled with many ups and downs, three ingredients to this company’s success has remained constant, it’s employees’: 
    1) resilience in the face of adversity,
    2) attitude to make the fight against cancer personal, and
    ) perseverance to master the skills our patients count on each and every day.  
Get the latest industry insights and exclusive deals straight to your inbox

Get the latest industry insights and exclusive deals straight to your inbox